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Background: The decision to perform surgery on older patients often presents as an ethical dilemma. The
purpose of this study is to investigate the impact of comorbidities on the clinical outcomes of older rectal
cancer surgery patients, with the goal of enabling healthcare professionals to evaluate the risk of surgery
for the treatment of cancer in older patients with comorbid chronic disease.
Methods: This study included 320 patients >60 years of age who were treated from 2004e2009 at
a medical center in northern Taiwan. Logistic regression and Cox proportional hazards regression were
used to determine if various chronic diseases (e.g., hypertension, diabetes, cardiovascular disease,
cerebrovascular disease) increase the risk of in-hospital complications and 1-year mortality.
Results: In the multivariate analysis, the risk of in-hospital complications for diabetic patients was 3.43
times that of nondiabetic patients (95% conﬁdence interval [CI]: 1.13e10.37). For patients with
cerebrovascular disease, the risk was 4.99 times that of those without cerebrovascular disease (95% CI:
1.30e19.07). In addition, patients 80 years of age demonstrated signiﬁcantly higher 1-year mortality
rates (HR ¼ 3.49, 95% CI:1.18e10.30). However, a history of hypertension, diabetes, cardiovascular
disease, or cerebrovascular disease was not a signiﬁcant predictor of 1-year mortality.
Conclusion: Older patients with comorbidities are at a higher risk of in-hospital complications following
rectal cancer surgery, whereas the presence of comorbidities did not show a signiﬁcant adverse effect on
1-year mortality in the present study. We suggest using population-based data to establish effective
therapeutic strategies for treating each comorbidity.
Copyright  2012, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Colorectal cancer is the second leading cause of death in
developed countries among patients with malignancies1,2. During
the past 20 years, the incidence of colorectal cancer in older
patients has increased by over 70%3. Among the aging population,
the total number of cases of colorectal cancer is increasing as well.
Studies have demonstrated that age is a risk factor that affects
surgical outcome, and surgery is infrequently offered to older
cancer patients because of the increased risk of surgical morbidity
and mortality4. Thus, the decision to perform surgery on older
patients often presents as an ethical dilemma5.
A number of studies have demonstrated that in highly functional
elderly patients without comorbidities, postoperative clinicalerest.
Section 2, Zhongshan North
).
iwan Society of Geriatric Emergenoutcomes are similar to those of younger patients6,7; however,
other research has shown that older cancer patients probably
receive less curative treatment compared with younger patients8.
The higher prevalence of chronic diseases in older patients may
limit treatment choices; for example, patients with chronic
diseases may not be candidates for surgery or chemotherapy9,10,
and this inﬂuences the therapeutic outcome of cancer treatment.
Furthermore, irrespective of whether or not surgery is permitted,
chronic diseases also complicate surgery, increasing the risk of
complications.
Several studies have explored the impact of comorbidities on
the surgical outcome of colorectal cancer, demonstrating that the
risk of surgical complications and postoperative mortality are
higher in patients with chronic obstructive pulmonary disease,
deep vein thrombosis, neurological comorbidities, or cardiorespi-
ratory comorbidities11,12. However, heterogeneity exists between
colon cancer and rectal cancer, and their risk factors are different13.
It has been suggested that investigations of colon or rectal cancer
should be separated.cy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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of comorbidities on the clinical outcomes of older rectal cancer
patients9,14. Therefore, the aim of this study is to determine the
impact of comorbidities on surgical complications and themortality
of older rectal cancer patients, with the hope of providing more
information on surgical risk that could be used to evaluate patients
with different chronic diseases. This is critical for surgical planning
and therapy because the proper evaluation of the comorbid condi-
tions and considerations of a treatment strategy could decrease the
risk of surgical complications and mortality in older patients.
2. Methods
The study included 320 patients >60 years of age who were
treated for resected rectal cancer between 2004e2009 at a medical
center in northern Taiwan. Datawere retrieved from outpatient and
inpatient claims data and the cancer registry. The outpatient and
inpatient claims data included demographics, diagnoses, treat-
ments, and medical expense records. The cancer registry data
included the histological types of the treated tumors, treatment
intensity, and survival status. The characteristics of the patients and
surgical outcomes were retrieved from both databases.
The comorbidities included in the present study were hyper-
tension, diabetes, cardiovascular disease, and cerebrovascular
disease, all which are common in Taiwan. The principal and
secondary diagnoses in preoperative claims data were used to
determine whether a patient had any of these diseases prior
to surgery. The diagnosis of a comorbidity was deﬁned according
to the ICD-9 CM code for hypertension (401.XXe405.XX),
diabetes (250.XX), cardiovascular disease (390.XXe398.XX,
411.XXe429.XX), and cerebrovascular disease (430.XXe438.XX).
Abdominoperineal resection (APR), lowanterior resection (LAR),
and anterior resection (AR) are common types of resection. Only
two categories of resection type were indicateddAPR or otherdin
the present study. To specify the effects of chemotherapy on
surgical outcome, we included only the claims data gathered before
and 6months after surgery in order to determinewhether a patient
underwent chemotherapy. Tumor stage was determined in accor-
dance with the AJCC/UICC stage classiﬁcation, and stage was
grouped into early (Stages I-II) and advanced (Stages III-IV) for
analyses. Tumor size was deﬁned according to two levels, with
a breakpoint value equal to the median of 4.5 mm. In addition, the
demographic characteristics of patients at baseline were deter-
mined, including age and sex. Age was grouped into three cate-
gories (60e69, 70e79, and 80 years).
Dekker et al indicated that older patients with colorectal cancer
who survive the ﬁrst year demonstrate the same rate of cancer-
related survival as younger patients. Therefore, the treatment of
older patients with colorectal cancer should focus on perioperative
care and the ﬁrst postoperative year15. For this reason, the
endpoints that were evaluated in the present study included in-
hospital complications and 1-year mortality after surgery. Accord-
ing the criteria of previous studies, we deﬁned in-hospital
complications as infections and other cardiovascular, respiratory,
gastrointestinal, or urological complications16e18. Patients who
developed any of these complications were classiﬁed as having an
in-hospital complication. In order to avoid overestimating the
incidence of complications, comorbidities that were present 1
month before surgery were excluded. Mortality is frequently used
to measure the quality of surgery and has been used in numerous
studies as a quality indicator of colorectal cancer surgery19e22.
Similarly, we used mortality at 1 year postsurgery as a measure-
ment of survival. Survival time, in days, was measured from the
date of surgery to the date of death or last follow-up examination
within 1 year postsurgery.Differences in the proportions of in-hospital complications
among various patient characteristicswere compared using the Chi-
square test (or Fisher exact test, as appropriate), anddifferences in 1-
yearmortalitywere compared using the log-rank test. The impact of
comorbidities on surgical complications and 1-year mortality were
analyzed using multiple logistic regression or Cox proportional
hazards regression, respectively, after controlling for sex, age, tumor
stage, tumor size, resection type, and chemotherapy.
Each characteristic of a cancer patient is the result of a complex
array of physiologic and molecular variations23. Different patient
characteristics may inﬂuence surgical outcomes, and interactions
between comorbidities and prognostic factors should be consid-
ered. For this reason, interaction terms were incorporated into the
statistical model in order to determine the interactions between
comorbidities, sex, age, and cancer stage. If the interaction was
signiﬁcant, subgroup analyses were further performed to deter-
mine the potential differential effects of the comorbidities across
different subgroups of patients.
The sample size of the present study was not large enough;
however, we used the bootstrapping technique to obtain robust
estimates (1000 repetitions) from the multivariate models. Statis-
tical analyses were performed using SPSS software (version 17.0,
SPSS Inc., Chicago, IL) and STATA software (version 10, StataCorp,
College Station, TX). The two-sided tests deﬁned statistical signiﬁ-
cance as p < 0.05.
3. Results
In the present study, the in-hospital complication rate was 11.9%
and the 1-year mortality rate was 11.3%. Table 1 shows the patient
characteristics and surgical outcomes. There were 142 (44.4%)
female and 178 (55.6%) male patients. One hundred and forty-ﬁve
(45.3%) people were 60e69 years of age, 115 (35.9%) were 70e79
years, and 60 (18.8%) were 80 years. The number of patients
with early-stage and advanced-stage cancer were 152 (47.5%) and
168 (52.5%), respectively. One hundred and seventy-nine patients
(55.9%) had tumor sizes 45 mm, while 141 (44.1%) had tumors
>45 mm. The percentages of patients who had hypertension, dia-
betes, cardiovascular disease, or cerebrovascular disease were
35.6%, 19.7%, 25%, and 8.1%, respectively. The in-hospital compli-
cation rate of patients with diabetes was 22.2%, which is signiﬁ-
cantly higher than the rate of 9.3% determined for patients without
diabetes (p < 0.01). In addition, the in-hospital complication rate
was signiﬁcantly higher in patients with cerebrovascular disease
compared with those without such diseases (34.6% vs. 9.9%,
p < 0.001). One-year mortality was signiﬁcantly associated age and
tumor stage. One-year mortality was 21.7% among patients 80
years, higher than those aged 60e69 years (7.6%) and 70e79 years
(10.4%). Patients with advanced-stage diseases demonstrated
a higher 1-year mortality rate compared with those with
early-stage diseases (17.9% vs. 3.9%, p < 0.001). Nevertheless, the
development of in-hospital complications was not signiﬁcantly
associated with hypertension or cardiovascular disease, and 1-year
mortality was not signiﬁcantly associated with any comorbidity.
The results of the risk factor analyses for in-hospital complica-
tions and 1-year mortality are shown in Table 2. The risk of
developing complications among patients with diabetes or cere-
brovascular diseases was signiﬁcantly higher after controlling for
sex, age, tumor stage, tumor size, chemotherapy, and resection
type. The risk of developing in-hospital complications among dia-
betic patients was 3.43 times (95% conﬁdence interval [CI]:
1.13e10.37) that of nondiabetic patients. In patients with cerebro-
vascular disease, the risk was 4.99 times (95% CI: 1.30e19.07) that
of those without cerebrovascular disease. Furthermore, the
mortality risk of patients 80 years was 3.49 times (95% CI:
Table 2
Results of multivariate analysis of the factors that inﬂuence surgical outcomes
(calculated from 1000 bootstrap replications).
In-hospital
complication
1-year mortality
OR 95% CI HR 95% CI
Sex (ref: female)
Male 0.68 0.28e1.64 1.47 0.60e3.65
Age (ref: 60e69 y)
70e79 y 0.87 0.30e2.55 1.33 0.50e3.56
80 y 2.21 0.71e6.85 3.49* 1.18e10.30
Tumor stage (ref: early stage)
Advanced stage 0.61 0.22e1.66 9.79 0.25e378.35
Tumor size (ref:  45 mm)
>45 mm 1.52 0.62e3.75 1.50 0.67e3.37
Chemotherapy 2.55 0.80e8.16 0.32 0.09e1.19
Resection type (ref: others)
APR 0.91 0.37e2.22 0.94 0.39e2.25
Hypertension 0.51 0.15e1.78 1.23 0.51e3.12
Diabetes 3.43* 1.13e10.37 0.99 0.02e48.68
Cardiovascular disease 1.21 0.36e4.03 1.12 0.47e2.67
Cerebrovascular disease 4.99* 1.30e19.07 1.31 0.00e22,470.58
*p < 0.05.
APR ¼ abdominoperineal resection.
Table 1
Characteristics of the patients and surgical outcomes.
Study
population
In-hospital
complication rate
P (c2 ) 1-year
mortality
P (log-rank)
(n ¼ 320) (n ¼ 38) (n ¼ 36)
n (%) % %
Sex
Female 142 (44.4) 14.8 0.150 10.6 0.712
Male 178 (55.6) 9.6 11.8
Age (y)
60e69 y 145 (45.3) 9.7 0.096 7.6 0.014
70e79 y 115 (35.9) 10.4 10.4
80 y 60 (18.8) 20.0 21.7
Tumor stage
Early 152 (47.5) 12.5 0.742 3.9 <0.001
Advanced 168 (52.5) 11.3 17.9
Tumor size
45mm 179 (55.9) 10.1 0.257 9.5 0.289
>45mm 141 (44.1) 14.2 13.5
Chemotherapy
No 99 (30.9) 9.1 0.303 9.1 0.468
Yes 221 (69.1) 13.1 12.2
Resection type
Other 180 (56.3) 11.7 0.896 12.2 0.529
APR 140 (43.8) 12.1 10.0
Hypertension
No 206 (64.4) 11.2 0.598 10.2 0.412
Yes 114 (35.6) 13.2 13.2
Diabetes
No 257 (80.3) 9.3 <0.01 11.3 0.968
Yes 63 (19.7) 22.2 11.1
Cardiovascular disease
No 240 (75.0) 10.0 0.073 9.6 0.105
Yes 80 (25.0) 17.5 16.3
Cerebrovascular disease
No 294 (91.9) 9.9 <0.001 10.9 0.468
Yes 26 (8.1) 34.6 15.4
APR ¼ abdominoperineal resection.
Rectal Cancer Surgery Outcomes in Older Patients 2871.18e10.30) that of patients aged 60e69 after controlling for
prognostic factors, demonstrating a statistical level of signiﬁcance.
Nevertheless, the 1-year mortality rates of patients with hyper-
tension, cardiovascular disease, or cerebrovascular disease were all
greater than the rates of patients without these diseases, though
these results were not statistically signiﬁcant. Survival curve-
adjusted prognostic factors according to comorbidity are pre-
sented in Fig. 1. No signiﬁcant comorbidity-associated differences
were noted in the 1-year survival curve.
Interaction terms were included in the multivariate analyses,
which included 1000 bootstrap replications in order to determine
the interaction effects of the comorbidities, sex, age, and cancer
stage (data not shown). Interactions between comorbidities and
sex, comorbidities and age, and comorbidities and tumor stage
were not observed; therefore, further subgroup analyses were not
performed.
4. Discussion
After adjusting for other prognostic factors, the presence of dia-
betes or cerebrovascular disease signiﬁcantly affected the risk of
surgical complications among older patients undergoing surgical
treatment for rectal cancer, whereas the presence of comorbidities
did not demonstrate a signiﬁcant adverse effect on 1-yearmortality.
Hyperglycemia impairs the immune system, thereby increasing
the risk of infection and preventing normal wound healing24.
Therefore,mostprevious studieson thepostsurgical complicationsof
diabetic patients treated using colorectal resection for the treatment
of cancer are focused on infected surgical wounds. Diabetes mellitus
has been shown to play a signiﬁcant role in predisposing an indi-
vidual to surgical site infections following colorectal resection25,26.
Sehgal et al found that among diabetic patients who undergo colo-
rectal cancer resection, higher than normal glucose levels are asso-
ciated with a greater risk of developing surgical site infections. They
concluded that diabetic patients who require a colectomy should
have tightly controlled glucose levels, avoid the placement of drains,
and receive prophylactic antibiotics for <24 hours26. Moreover, the
study by Cong et al also conﬁrmed that diabetes mellitus is a risk
factor for anastomotic leakage following rectal surgery27.
Fewstudieshave evaluated the impactof cerebrovasculardisease
on postsurgical complications following colorectal cancer surgery.
The study by Iancu et al reported that patients with cerebrovascular
disease are at a greater risk for anastomotic leakage following
colorectal cancer surgery28. A greater proportion of Asian patients
have cerebral hemorrhages and intracranial vascular diseases than
their Western counterparts; cerebrovascular disease has consis-
tently been reported as the second most common cause of death in
Taiwan, second only to malignancy29. Thus, the relationship
betweenpostsurgical care following treatment for rectal cancer and
cerebrovascular treatment (such as antiplatelet or anticoagulant
therapy) in older Asian patients warrants further investigations.
Some studies have examined the relationship between surgical
complications and comorbidities in older patients following
resection for the treatment of colorectal cancer. Pedrazzani et al
found that those with preexisting cardiovascular diseases demon-
strate higher complication rates30. Janssen-Heijnen et al reported
that postoperative morbidity is higher among those with reduced
pulmonary function, cardiovascular disease, or neurological
comorbidities9. In the present study, patients with diabetes or
cerebrovascular disease were at increased risk of surgical compli-
cations, but those with hypertension or cardiovascular disease did
not demonstrate increased risk. This discrepancy could be due to
differences in the deﬁnitions of these conditions and the duration
of the complications. If a complication was present before surgery,
it was not considered a surgical complication in the present study;
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Fig. 1. Survival curves of patients diagnosed with a comorbidity.
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lower than those reported in other studies. The screening criteria
for complications might also have led us to different results than
other studies. Furthermore, the present study included complica-
tions that appeared only during the postsurgical period while the
patient was hospitalized; however, previous studies used different
deﬁnitions for the duration of complications, ranging from 1e3
months postsurgery or they used criteria that were the same as
our study. Differences in the study designs that resulted in varia-
tions in the duration of the complications that were observed
produced large differences in the incidences of postsurgical
complications that were reported across different studies.
In the present study, the 1-year mortality rates were greater in
patients with hypertension, cerebrovascular disease, and cerebro-
vascular disease than patients without these diseases, but these
differences did not achieve a statistical level of signiﬁcance.
Because the lower number of deaths due to the shorter postsurgical
duration may have resulted in poor statistical reliability, Zaslavsky
et al suggested using an extended duration of assessment in order
to overcome this problem31. Previous studies on older patients with
cancer have classiﬁed postsurgical survival as long-term or short-
term. Janssen-Heijnen et al used overall survival as a mortality
measure, revealing that mortality risk is greater in older rectal
surgery patients with cardiovascular disease, chronic obstructive
pulmonary disease, diabetes, and hypertension9. Alves et al used
in-hospital death as an endpoint, and only neurological comor-
bidities were classiﬁed as risk factors12. Nonetheless, these studies
suggest that chronic disease could inﬂuence both short- and long-
term survival. On the contrary, the impact of chronic disease on the
mortality rate did not achieve a level of statistical signiﬁcance in the
present study. Thismay be due to the smaller sample size or the fact
that patients in the study hospital were treated with an appropriate
level of caution. Healthcare professionals might have been aware
that the mortality of older patients with chronic disease may
increase because of their poor health status, and thus they may
have exercised more care when treating older patients.In our study, age did not signiﬁcantly affect the rate of in-
hospital complications among older rectal cancer surgical
patients, but age did signiﬁcantly inﬂuence the 1-year mortality:
the 1-year mortality risks of patients aged 70e79 years and >80
years were 1.33 and 3.48 times the risk for those aged 60e69 years,
respectively. The International Society for Geriatric Oncology
deﬁnes old age as >70 years. Using this deﬁnition, Kesisoglou et al
found that patients>70 years of age demonstrate higher morbidity
and mortality rates. This observation is probably the result of these
patients having a poor overall health status3. Most previous studies
on postsurgical mortality in elderly colorectal cancer patients
deﬁne elderly as >80 years. It has been established that “age” is
a risk factor of early postsurgical mortality, and that short-term
postsurgical mortality is signiﬁcantly greater in older
patients32,33. The life expectancy of a patient who does not undergo
surgery cannot be predicted, but pain, poor general health, and
complications caused by tumor obstruction are all factors that
diminish the patient’s quality of life if the tumor is not removed.
Therefore, by minimizing the operative risk and ensuring careful
intraoperative and postoperative monitoring, surgical treatment of
rectal cancer can be considered in geriatric patients34.
This study has two limitations. First, because datawere collected
only from the study hospital, this study lacked information on the
development of comorbidities. The progression of a comorbidity
could have induced poor health status and affected morbidity or
mortality; therefore, the effects of comorbidities on surgical
outcomes cannot be exactly estimated. Second, treatment intensity
and disease severity would similarly have been underestimated
because of data limitations.
4. Conclusions
Healthcare professionals are facing an inevitable increase in the
number of older cancer patients. Whether or not to perform
surgery on an older patient should be carefully considered, espe-
cially when surgery remains as the most effective therapy. This
Rectal Cancer Surgery Outcomes in Older Patients 289study indicates that, although comorbidities can affect in-hospital
complications, 1-year postsurgery mortality was unaffected.
Although we strictly controlled for cancer stage, presurgical
comorbidities, and other prognostic factors, selection bias still
exists, as in previous studies, because our samples were derived
from only one hospital. Therefore, we recommend that future
research use population-based data in order to establish effective
therapeutic strategies for the treatment of speciﬁc comorbidities.
Moreover, although we found that comorbidities affect in-hospital
complications, our study population consisted of only older
patients. Thus, we recommend comparisons between older and
younger groups in order to determine whether this effect occurs
only in older patients. Furthermore, in order to understand survival
differences, we propose comparing the clinical outcomes of older
patients who have undergone surgery against the outcomes of
older patients who have not.References
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